Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301
Autor: | Reungwetwattana, Thanyanan, Cho, Byoung Chul, Lee, Ki Hyeong, Pang, Yong Kek, Fong, Chin Heng, Kang, Jin Hyoung, Lee, Yun-Gyoo, Lim, Chun Sen, Danchaivijitr, Pongwut, Lim, Yueh Ni, Lee, Youngjoo, How, Soon Hin, Geater, Sarayut, Lee, Sung Sook, Min, Young Joo, Kim, Joo-Hang, Lee, Jong-Seok, Lee, Gyeong-Won, Soo, Ross A., Lee, Sae Young, Choi, SeokYoung, Ahn, Myung-Ju |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2023 18(10):1351-1361 |
Databáze: | ScienceDirect |
Externí odkaz: |